Emerging Stocks Down Under 30 March 2021: SomnoMed, 5G Networks, Buddy Technologies

SomnoMed: Risk and low growth is not a good combination

In today’s edition of Emerging Stocks Down Under, headquartered in Sydney, SomnoMed is an oral device manufacturer and developer with a stock chart that reminds us of a roller-coaster. This company has bounced between its 52-week low of $0.90 and a high of $2.58, mainly due to its extremely low average three-month daily volume of 30,000. The company’s products focus on preventing teeth grinding and helping obstructive sleep apnoea, but the question remains, will owning this stock help you sleep better at night?

 

Also in today’s edition, a look at internet-based product company 5G Networks (ASX: 5GN) and light bulb and energy monitoring company Buddy Technologies (ASX: BUD).

Click here to read the previous edition of Emerging Stocks Down Under published 23 March 2021

For in-depth research reports or to keep up-to-date on the latest Stocks Down Under news see our parent company, Pitt Street Research, or follow us on Facebook and Twitter.